Pharma Bavaria International GmbH

pharma-bavaria.com

Pharma Bavaria International is a global reach company that distributes and promotes high-quality pharmaceuticals with well-researched ingredients. In line with our vision - Access to Quality Healthcare - we offer a vast portfolio of prescription’s medicines that includes different therapeutic options for different pathologies, plus Pharma Bavaria International has LAB BOTANIC BAVARIA, an umbrella that covers OTCs and a range of herbal/supplement products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

MEDISON PHARMA ANNOUNCES EXTENSION OF MULTI-TERRITORIAL AGREEMENT WITH IMMUNOCORE AND EXPANSION INTO AUSTRALIA AND NEW ZEALAND

Medison Pharma | May 30, 2022

news image

Medison Pharma a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced the addition of new markets to its multi-territorial agreement with Immunocore Holdings plc a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease. The multi-territorial agreem...

Read More

ASHP DEMANDS MORE MANUFACTURING OF VENTILATOR DRUGS FOR COVID-19

PharmaNewsIntelligence | April 07, 2020

news image

ASHP recently urged the Trump administration to take action to address shortages of supportive ventilator drugs as the number of confirmed COVID-19 cases continues to rise. The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more patients. In an official letter to Vice President Mike Pence, ASHP requested the administration release drugs from the Strategic Na...

Read More

Business Insights

LTS TAKES NEXT STEP IN ITS GROWTH JOURNEY WITH THE ACQUISITION OF TAPEMARK INC.

LTS Lohmann Therapie-Systeme AG | August 23, 2022

news image

LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches Oral Thin Films and Micro Array Patches (MAP) ...

Read More

PREPARATION PRODUCTS OF YILING PHARMA APPROVED BY FDA FOR LAUNCH IN THE US MARKET

Yiling Pharmaceutical Co | September 19, 2020

news image

Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter referred to as the "FDA"), which were submitted by Yiling Wanzhou International Pharmaceutical Co., Ltd., one of the wholly-owned subsidiaries of Yiling Pharmaceutical Co., Ltd., meaning that these products are approved to be produced and sold i...

Read More
news image

Pharmacy Market

MEDISON PHARMA ANNOUNCES EXTENSION OF MULTI-TERRITORIAL AGREEMENT WITH IMMUNOCORE AND EXPANSION INTO AUSTRALIA AND NEW ZEALAND

Medison Pharma | May 30, 2022

Medison Pharma a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced the addition of new markets to its multi-territorial agreement with Immunocore Holdings plc a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease. The multi-territorial agreem...

Read More
news image

ASHP DEMANDS MORE MANUFACTURING OF VENTILATOR DRUGS FOR COVID-19

PharmaNewsIntelligence | April 07, 2020

ASHP recently urged the Trump administration to take action to address shortages of supportive ventilator drugs as the number of confirmed COVID-19 cases continues to rise. The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more patients. In an official letter to Vice President Mike Pence, ASHP requested the administration release drugs from the Strategic Na...

Read More
news image

Business Insights

LTS TAKES NEXT STEP IN ITS GROWTH JOURNEY WITH THE ACQUISITION OF TAPEMARK INC.

LTS Lohmann Therapie-Systeme AG | August 23, 2022

LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches Oral Thin Films and Micro Array Patches (MAP) ...

Read More
news image

PREPARATION PRODUCTS OF YILING PHARMA APPROVED BY FDA FOR LAUNCH IN THE US MARKET

Yiling Pharmaceutical Co | September 19, 2020

Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter referred to as the "FDA"), which were submitted by Yiling Wanzhou International Pharmaceutical Co., Ltd., one of the wholly-owned subsidiaries of Yiling Pharmaceutical Co., Ltd., meaning that these products are approved to be produced and sold i...

Read More